Abstract |
A trifluoroacetamide analogue of siastatin B, (3S,4S,5R,6R)-6-(trifluoroacetamido)-4,5-dihydroxy-3-piperidine carboxylic acid has been chemically synthesized. This compound, as well as the previously synthesized analogue, (3R,4R,5R,6R)-6-(trifluoroacetamido)-3,4,5-trihydroxy-3-piperid inecarboxylic acid, showed marked inhibitory activity against beta-glucuronidase and significant inhibition of experimental pulmonary metastasis of the highly metastatic melanoma B16.
|
Authors | Y Nishimura, T Kudo, S Kondo, T Takeuchi, T Tsuruoka, H Fukuyasu, S Shibahara |
Journal | The Journal of antibiotics
(J Antibiot (Tokyo))
Vol. 47
Issue 1
Pg. 101-7
(Jan 1994)
ISSN: 0021-8820 [Print] England |
PMID | 8119851
(Publication Type: Journal Article)
|
Chemical References |
- 6-trifluoroacetamido-4,5-dihydroxy-3-piperidinecarboxylic acid
- Acetamides
- Antineoplastic Agents
- Piperidines
- siastatin
- Glycoside Hydrolases
- Glucuronidase
|
Topics |
- Acetamides
(chemical synthesis, therapeutic use)
- Animals
- Antineoplastic Agents
(chemical synthesis, therapeutic use)
- Glucuronidase
(antagonists & inhibitors, metabolism)
- Glycoside Hydrolases
(antagonists & inhibitors)
- Liver
(drug effects, enzymology)
- Lung Neoplasms
(prevention & control)
- Male
- Melanoma, Experimental
(drug therapy)
- Mice
- Neoplasm Metastasis
(prevention & control)
- Piperidines
(chemical synthesis, therapeutic use)
|